Company Filing History:
Years Active: 2024
Title: Chunning Yang: Innovator in Antibody Molecules
Introduction
Chunning Yang is a prominent inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibody molecules that target specific receptors involved in cancer treatment.
Latest Patents
Chunning Yang holds a patent for "Antibody molecules and conjugates." This patent relates to antibody molecules that bind to the epidermal growth factor receptor (EGFR) and/or c-Met, along with conjugates containing these antibody molecules. The applications of these innovations are particularly relevant in the treatment of cancer.
Career Highlights
Chunning Yang is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work focuses on advancing therapeutic solutions that can significantly impact patient care and treatment outcomes.
Collaborations
Chunning Yang has collaborated with notable colleagues in his field, including Frank Irvine Comer and Yariv Mazor. These partnerships enhance the research and development efforts within the biotechnology sector.
Conclusion
Chunning Yang's contributions to antibody molecule development exemplify the innovative spirit in the fight against cancer. His work continues to pave the way for new therapeutic options that can improve patient outcomes.